|
IDH3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.025700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.345600E-01 |
| Normal-vs-Stage2 |
7.831000E-01 |
| Normal-vs-Stage3 |
8.671600E-02 |
| Normal-vs-Stage4 |
1.794330E-02 |
| Stage1-vs-Stage2 |
8.003000E-01 |
| Stage1-vs-Stage3 |
2.443200E-01 |
| Stage1-vs-Stage4 |
3.477000E-01 |
| Stage2-vs-Stage3 |
3.669800E-01 |
| Stage2-vs-Stage4 |
2.944000E-01 |
| Stage3-vs-Stage4 |
8.634800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.302000E-03 |
| Normal-vs-AfricanAmerican |
5.625800E-01 |
| Normal-vs-Asian |
3.499800E-01 |
| Caucasian-vs-AfricanAmerican |
1.466290E-02 |
| Caucasian-vs-Asian |
8.932200E-01 |
| AfricanAmerican-vs-Asian |
3.835400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.538230E-02 |
| Normal-vs-Female |
6.871600E-01 |
| Male-vs-Female |
1.513430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.481500E-02 |
| Normal-vs-Extreme_Weight |
1.362590E-01 |
| Normal-vs-Obese |
1.268760E-01 |
| Normal-vs-Extreme_Obese |
4.754000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.535400E-01 |
| Normal_Weight-vs-Obese |
7.921200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.363800E-01 |
| Extreme_Weight-vs-Obese |
8.550000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.902000E-01 |
| Obese-vs-Extreme_Obese |
2.684000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.675700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.424370E-01 |
| Normal-vs-Age(61-80Yrs) |
1.765810E-01 |
| Normal-vs-Age(81-100Yrs) |
3.478800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.864000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.862350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.957600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.987000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.276100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.333700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.590200E-02 |
| Normal-VS-Type2 PRCC |
1.556430E-01 |
| Normal-VS-KIRP CIMP |
1.91646999999628E-05 |
| Normal-VS-Unclassified PRCC |
1.510810E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.273400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.662500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.805200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.496200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.554600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.970400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.818200E-02 |
| Normal-vs-N1 |
1.257590E-02 |
| Normal-vs-N2 |
3.011100E-04 |
| N0-vs-N1 |
2.574200E-01 |
| N0-vs-N2 |
1.626160E-01 |
| N1-vs-N2 |
4.404000E-01 |
|
|
